283 results
8-K
EX-99.1
LXRX
Lexicon Pharmaceuticals Inc
2 May 24
Lexicon Pharmaceuticals Reports First Quarter 2024
4:07pm
launch, with the expansion of market access we expect to begin around the middle of this year enabling an inflection in the second half of the year,” said … negotiations with payers regarding expanded market access. Net sales for the quarter were $1.1 million reflecting 63 percent growth from the previous
8-K
EX-99.1
gtc8p1
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
EX-10.1
1rd1 aukbmgpk
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
EX-1.1
zgyfrr3de8ovv9m
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
424B5
xki anek6klh7
29 Dec 23
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
cf6x s8uf
8 Nov 23
Lexicon Pharmaceuticals Reports Third Quarter 2023
7:22am
8-K
EX-99.1
wc8oshuveuu38h
31 Jul 23
Lexicon Elects Diane E. Sullivan to Board of Directors
4:02pm
8-K
EX-1.1
hxv79
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
424B5
yii pncsdx8ald
1 Jun 23
Prospectus supplement for primary offering
9:08pm
8-K
u3ufd9c e6a4q7e
31 May 23
Lexicon Announces Proposed Public Offering of Common Stock
4:17pm
424B5
9c5da
31 May 23
Prospectus supplement for primary offering
4:07pm